Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of GSK's AFX-3772?
AFX-3772 is a conjugate vaccine commercialized by GSK, with a leading Phase II program in Streptococcal Pneumonia. According to Globaldata,...